# If you had invested $1,000 in Bristol-Myers Squibb Company (BMY)

Source: https://www.equity-rank.com/if-you-invested/BMY

10 years ago (Mon, Nov 21, 2016), $1,000 in BMY grew to **$1,480** by Fri, Nov 20, 2026 with dividends reinvested ($1,036 on price alone). The same $1,000 in SPY grew to $3,672. Along the way BMY fell as much as -47.7% from a high. Past results do not tell you what happens next.

| Invested | BMY, dividends reinvested | Per year | Worst fall | SPY | SPY per year |
| --- | --- | --- | --- | --- | --- |
| 1 year ago | $1,337 | +33.7% | -15.9% | $1,069 | +6.9% |
| 3 years ago | $1,385 | +11.5% | -29.9% | $1,575 | +16.3% |
| 5 years ago | $1,268 | +4.9% | -47.7% | $1,578 | +9.6% |
| 10 years ago | $1,480 | +4.0% | -47.7% | $3,672 | +13.9% |

Today: model fair value $97.88 against a $58.80 price (gap +66.5%).

Split-adjusted closes; 40 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 20, 2026.

[Full BMY valuation](https://www.equity-rank.com/stocks/BMY) · [Other companies](https://www.equity-rank.com/if-you-invested)

---

Fair value is a model estimate under stated assumptions — not a price target, not a prediction, and not a recommendation. This page is research information, not investment advice. Equity Rank is not a registered investment adviser.
